ANSBERT GADICKE Insider Trading $CGEM Cullinan Oncology, Inc.
Get free email notifications about insider trading for ANSBERT GADICKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANSBERT GADICKE. ANSBERT GADICKE is 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in CHIASMA, INC ($CHMA) and Director in Radius Health, Inc. ($RDUS) and 10% Owner in Harpoon Therapeutics, Inc. ($HARP) and Director in Allovir, Inc. ($ALVR) and Director in TCR2 THERAPEUTICS INC. ($TCRR) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and Director in iTeos Therapeutics, Inc. ($ITOS) and 10% Owner in Repare Therapeutics Inc. ($RPTX) and Director in Cullinan Management, Inc. ($CGEM).
ANSBERT GADICKE in Cullinan Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: Director
Holdings: 281,268 shares
Latest Transaction: Jan 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ANSBERT GADICKE in Cullinan Oncology, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALVR, CHMA, CGEM, HARP, ITOS, RDUS, RPTX, RIGL, TCRR, HOWL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 649,030 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 2,276,692 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 3,551,640 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 1,136,525 | 0 | 0 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | J | 4.30 | 88,824 | 381,943 | 88,824 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | J | 4.30 | 262,114 | 1,127,090 | 262,114 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | J | 0.00 | 649,030 | 0 | 649,030 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | J | 0.00 | 2,276,692 | 0 | 2,276,692 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | J | 0.00 | 3,551,640 | 0 | 3,551,640 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Option Exercise | J | 0.00 | 1,136,525 | 0 | 1,136,525 | |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Buy | P | 21.00 | 300,000 | 6,300,000 | 7,913,887 | 7.6 M to 7.9 M (+3.94 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 649,030 | 0 | 7,613,887 | 7 M to 7.6 M (+9.32 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 2,276,692 | 0 | 6,964,857 | 4.7 M to 7 M (+48.56 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 3,551,640 | 0 | 4,688,165 | 1.1 M to 4.7 M (+312.50 %) |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 1,136,525 | 0 | 1,136,525 | 0 to 1.1 M |
| Jan 14 2021 | CGEM | Cullinan Managemen ... | GADICKE ANSBERT | Director | Buy | J | 0.00 | 281,268 | 0 | 281,268 | 0 to 281.3 K |
Page: 1